Literature DB >> 3023529

Characterization of the IE110 gene of herpes simplex virus type 1.

L J Perry, F J Rixon, R D Everett, M C Frame, D J McGeoch.   

Abstract

We have determined the DNA sequence of the herpes simplex virus type 1 (HSV-1) gene encoding the immediate early protein IE110, which is involved in transcriptional activation of later virus genes. The locations of the 5' and 3' termini of IE110 mRNA together with the positions of two introns, were identified. Examination of the DNA sequence suggested that translation starts at the first ATG after the 5' terminus of the mRNA, and that both introns occur in protein-coding sequence. The predicted IE110 polypeptide contains 775 amino acids, and has a molecular weight of 78452. It contains a cysteine-rich region resembling regions found in several proteins which interact functionally with DNA. An antiserum was raised to the predicted C terminal amino acid sequence of the IE110 polypeptide and was shown to immunoprecipitate the native protein from HSV-1-infected cell extracts. The functional importance of regions of the protein was evaluated by construction of frameshift and deletion mutants of a plasmid-borne IE110 gene. The mutants were tested for IE110 function by short-term transfection assays, and the results were correlated with the DNA sequence and RNA mapping studies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023529     DOI: 10.1099/0022-1317-67-11-2365

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  101 in total

1.  Neither LAT nor open reading frame P mutations increase expression of spliced or intron-containing ICP0 transcripts in mouse ganglia latently infected with herpes simplex virus.

Authors:  Shun-Hua Chen; Lily Yeh Lee; David A Garber; Priscilla A Schaffer; David M Knipe; Donald M Coen
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  Herpes simplex virus 1 ICP0 phosphorylation site mutants are attenuated for viral replication and impaired for explant-induced reactivation.

Authors:  Heba H Mostafa; Thornton W Thompson; Anna S Kushnir; Steve D Haenchen; Adam M Bayless; Joshua G Hilliard; Malen A Link; Lisa A Pitcher; Emma Loveday; Priscilla A Schaffer; David J Davido
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

3.  Multimerization of ICP0, a herpes simplex virus immediate-early protein.

Authors:  J Chen; C Panagiotidis; S Silverstein
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

4.  Association of ICP0 but not ICP27 with purified virions of herpes simplex virus type 1.

Authors:  F Yao; R J Courtney
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

Review 5.  Peculiarities of herpes simplex virus (HSV) transcription: an overview.

Authors:  Július Rajcáni; Vojvodová Andrea; Rezuchová Ingeborg
Journal:  Virus Genes       Date:  2004-04       Impact factor: 2.332

Review 6.  Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1.

Authors:  Ryan Hagglund; Bernard Roizman
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

7.  The B-cell and neuronal forms of the octamer-binding protein Oct-2 differ in DNA-binding specificity and functional activity.

Authors:  C L Dent; K A Lillycrop; J K Estridge; N S Thomas; D S Latchman
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

8.  Herpes simplex virus type 1 ICP0 plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA.

Authors:  W Z Cai; P A Schaffer
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

9.  Point mutations in the herpes simplex virus type 1 Vmw110 RING finger helix affect activation of gene expression, viral growth, and interaction with PML-containing nuclear structures.

Authors:  R Everett; P O'Hare; D O'Rourke; P Barlow; A Orr
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  The herpes simplex virus regulatory protein ICP27 contributes to the decrease in cellular mRNA levels during infection.

Authors:  M A Hardwicke; R M Sandri-Goldin
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.